|
|
Volumn 311, Issue 5763, 2006, Pages 943-
|
|
Novel attacks on HIV move closer to reality
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIRETROVIRUS AGENT;
EMTRICITABINE;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
INTEGRASE INHIBITOR;
MK 0518;
TENOFOVIR;
UNCLASSIFIED DRUG;
ADENINE;
DRUG DERIVATIVE;
ORGANIC COMPOUND;
PHOSPHONIC ACID DERIVATIVE;
MEDICINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG SAFETY;
EPIDEMIC;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MEDICAL RESEARCH;
NONHUMAN;
PRIORITY JOURNAL;
PROPHYLAXIS;
SIMIAN IMMUNODEFICIENCY VIRUS;
UNITED STATES;
VIRUS TRANSMISSION;
ANIMAL;
ARTICLE;
GENETICS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
MOLECULAR EVOLUTION;
MONKEY DISEASE;
PRIMATE;
VIROLOGY;
HUMAN IMMUNODEFICIENCY VIRUS;
SIMIAN IMMUNODEFICIENCY VIRUS;
ADENINE;
ANIMALS;
ANTI-HIV AGENTS;
EVOLUTION, MOLECULAR;
HIV INFECTIONS;
HIV-1;
HUMANS;
ORGANIC CHEMICALS;
PHOSPHONIC ACIDS;
PRIMATES;
SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;
SIMIAN IMMUNODEFICIENCY VIRUS;
|
|
EID: 33144479493
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.311.5763.943 Document Type: Conference Paper |
|
Times cited : (10)
|
|
References (0)
|